I agree that this site is using cookies. You can find further informations here.
X
Wijnsma, Kioa L.
38  results:
Search for persons X
?
1

Mutations in Genes Encoding Subunits of the RNA Exosome as ..:

Wijnsma, Kioa L. ; Schijvens, Anne M. ; Bouwmeester, Romy N....
International Journal of Molecular Sciences.  25 (2024)  14 - p. 7604 , 2024
Link: https://doi.org/10.3390/..
 
?
2

Early Eculizumab Withdrawal in Patients With Atypical Hemol..:

Bouwmeester, Romy N. ; Duineveld, Caroline ; Wijnsma, Kioa L....
Kidney International Reports.  8 (2023)  1 - p. 91-102 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Eculizumab Rescue Therapy in Patients With Recurrent Atypic..:

Duineveld, Caroline ; Bouwmeester, Romy N. ; Wijnsma, Kioa L....
Kidney International Reports.  8 (2023)  4 - p. 715-726 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Proposal for individualized dosing of eculizumab in atypica..:

ter Avest, Mendy ; Bouwmeester, Romy N ; Duineveld, Caroline...
Nephrology Dialysis Transplantation.  38 (2022)  2 - p. 362-371 , 2022
Link: https://doi.org/10.1093/..
 
?
5

Case Report: Variable Pharmacokinetic Profile of Eculizumab..:

Bouwmeester, Romy N. ; Ter Avest, Mendy ; Wijnsma, Kioa L....
Frontiers in Immunology.  11 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
6

Long-term follow-up including extensive complement analysis..:

Michels, Marloes A. H. M. ; Wijnsma, Kioa L. ; Kurvers, Roel A. J....
Pediatric Nephrology.  37 (2021)  3 - p. 601-612 , 2021
Link: https://doi.org/10.1007/..
 
?
7

Heme as Possible Contributing Factor in the Evolvement of S..:

Wijnsma, Kioa L. ; Veissi, Susan T. ; de Wijs, Sem...
Frontiers in Immunology.  11 (2020)  - p. , 2020
Link: https://doi.org/10.3389/..
 
?
8

Correction to: Eculizumab in atypical hemolytic uremic synd..:

Wijnsma, Kioa L. ; Duineveld, Caroline ; Wetzels, Jack F. M..
Pediatric Nephrology.  34 (2019)  4 - p. 741-742 , 2019
Link: https://doi.org/10.1007/..
 
?
9

Eculizumab therapy monitoring: Residual hemolysis in altern..:

van den Heuvel, Lambertus ; Sarlea, Andrei ; Duineveld, Caroline...
Molecular Immunology.  102 (2018)  - p. 226 , 2018
Link: https://doi.org/10.1016/..
 
?
10

Eculizumab in atypical hemolytic uremic syndrome: strategie..:

Wijnsma, Kioa L. ; Duineveld, Caroline ; Wetzels, Jack F. M..
Pediatric Nephrology.  34 (2018)  11 - p. 2261-2277 , 2018
Link: https://doi.org/10.1007/..
 
?
11

Validity of the Patient Experiences and Satisfaction with M..:

PESaM Collaborating Group ; Kimman, Merel L. ; Wijsenbeek, Marlies S....
The Patient - Patient-Centered Outcomes Research.  12 (2018)  1 - p. 149-162 , 2018
Link: https://doi.org/10.1007/..
 
?
12

Glyco-iELISA: a highly sensitive and unambiguous serologica..:

Wijnsma, Kioa L. ; Veissi, Susan T. ; van Bommel, Sheila A. M....
Pediatric Nephrology.  34 (2018)  4 - p. 631-639 , 2018
Link: https://doi.org/10.1007/..
 
?
13

PP67 Validity Of A Questionnaire Assessing Patient Medicati..:

Kimman, Merel ; Wijsenbeek, Marlies ; Mostard, Remy...
International Journal of Technology Assessment in Health Care.  34 (2018)  S1 - p. 93-93 , 2018
Link: https://doi.org/10.1017/..
 
?
14

Unusual severe case of hemolytic uremic syndrome due to Shi..:

Wijnsma, Kioa L. ; Schijvens, Anne M. ; Rossen, John W. A....
Pediatric Nephrology.  32 (2017)  7 - p. 1263-1268 , 2017
Link: https://doi.org/10.1007/..
 
?
15

Development and Pretesting of a Questionnaire to Assess Pat..:

Kimman, Merel L. ; Rotteveel, Adrienne H. ; Wijsenbeek, Marlies...
The Patient - Patient-Centered Outcomes Research.  10 (2017)  5 - p. 629-642 , 2017
Link: https://doi.org/10.1007/..
 
1-15